Parasite | Eso | Sto | Cancer | ESD
[Gastric cancer 761. EGC]
001 | 101 | 201 | 301 | 401 | 501 | 601 | 701 | 801 | 901 | 1000
¿ÜºÎ Á¶Á÷°Ë»ç´Â "TUBULAR ADENOCARCINOMA, MODERATELY DIFFERENTIATED with focal signet ring cell carcinoma and extracellular mucin"À̾ú°í º» º´¿ø Àç°ËÀº M/D tubular adenocarcinoma¿´½À´Ï´Ù. ESD¸¦ ½ÃµµÇϽðڽÀ´Ï±î?
¹ÌºÐÈÈ¥Àç¾ÏÀÌ°í °æ°è°¡ ¸Å¿ì ºÒºÐ¸íÇÏ°í ±× Å©±â´Â 2cm°¡ ³Ñ¾ú±â ¶§¹®¿¡ ¼ö¼úÀ» ±ÇÇÏ¿´½À´Ï´Ù. ÃßÁ¤º¸´Ù ±íÀº °ÍÀ¸·Î ³ª¿Ô½À´Ï´Ù. ESD¸¦ ÇÒÁö ¸»Áö °áÁ¤ÇÏ´Â °ÍÀº ´Ã ¾î·Æ½À´Ï´Ù.
Stomach, radical total gastrectomy: Early gastric carcinoma
1. Location : middle third, Center at body and anterior wall
2. Gross type : EGC type IIc+IIb
3. Histologic type : mixed mucinous adenocarcinoma (mucinous carcinoma portion: 70%) and tubular adenocarcinoma, poorly (poorly cohesive) differentiated
4. Histologic type by Lauren : mixed
5. Size : 2.5x2.3 cm
6. Depth of invasion : invades submucosa (sm3) (pT1b)
7. Resection margin: free from carcinoma, safety margin: proximal 2.5 cm, distal 10.0 cm
8. Lymph node metastasis : no metastasis in 32 regional lymph nodes (pN0) (0/32: "2", 0/3; "3", 0/8; "4", 0/7; "5", 0/3; "6", 0/2; "7", 0/1; "9", 0/1; "8a", 0/4; "11p", 0/0; "12a", 0/2; "4sb", 0/0; "1", 0/1; "mesentery LN", 0/0)
9. Lymphatic invasion : not identified
10. Venous invasion : not identified
11. Perineural invasion : not identified
12. Peritoneal cytology : negative
13. AJCC stage by 8th edition: pT1b N0
ÃÖ±Ù¿¡´Â ¹ÌºÐÈ Á¶Á÷Çü ¾Ï¿¡ ´ëÇÑ ESD¸¦ ½ÃÇàÇÒ ¼ö ÀÖÁö¸¸, ¾ÆÁ÷±îÁö´Â 1cm ÀÌÇÏÀÇ signet ring cell carcinoma¿¡ ´ëÇÏ¿© ½ÃÇàÇÏ´Â °ÍÀÌ ¾ÈÀüÇÏ´Ù´Â ´Ù¼Ò º¸¼öÀûÀÎ ÀÔÀåÀ» °¡Áö°í ÀÖ½À´Ï´Ù.
© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà. EndoTODAY Endoscopy Learning Center. Lee Jun Haeng. (2019-6-7)